18F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 212-216

  Calvo, Felipe A ^a   Cabezón, Luis ^a   González, Carmen ^a   Soria, Alicia ^a   De La Mata, Dolores ^a   Gómez Espí, Marina ^a   García Alfonso, Pilar ^a   Álvarez, Emilio ^a   Carreras, José Luis ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

18F FDG PET; Neoadjuvant treatment; Nodal metastasis downstaging; Rectal cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; TEGAFUR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 78149359920     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.021     Document Type: Article

References (34)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. M.S. Roh, L.H. Colangelo, and M.J. ÓConnell Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 2009 5124 5130
3. H.J. Kim, and W.D. Wong Role of endorectal ultrasound in the conservative management of rectal cancers Semin Surg Oncol 19 2000 358 366
4. J.G. Guillem, J. Puig-La Calle Jr., and T. Akhurst Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography Dis Colon Rectum 43 2000 18 24
5. K.T. Hoffmann, B. Rau, and P. Wust Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia Strahlenther Onkol 178 2002 386 392
6. J. Guillem, D.B. Chessin, and J. Shia Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate endpoint J Clin Oncol 23 2005 3475 3479
7. C. Capirci, D. Rubello, and F. Chierichetti Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET Biomed Pharmacother 58 2004 451 457
8. H. Abdel-Nabi, R.J. Doerr, and D.M. Lamonica Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings Radiology 206 1998 755 760
9. M. Mukai, S. Sadahiro, and S. Yasuda Preoperative evaluation by whole-body 18Ffluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer Oncol Rep 7 2000 85 87
10. I. Kantorova, L. Lipska, O. Belohlavek, V. Visokai, M. Trubac, and M. Schneiderova Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making J Nucl Med 44 2003 1784 1788
11. S.L. Gearhart, D. Frassica, R. Rosen, M. Choti, R. Schulick, and R. Wahl Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer Ann Surg Oncol 13 2006 397 404
12. A.G. Heriot, R.J. Hicks, and E.G. Drummond Does positron emission tomography change management in primary rectal cancer? A prospective assessment Dis Colon Rectum 47 2004 451 458
13. F. Lordick, K. Ott, and B.J. Krause PET to assess early metabolic response and guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 8 2007 797 805
14. A. Sendler Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of esophagus and esophagogastric junction Recent Results Cancer Res 182 2010 167 177
15. American Joint Committee on Cancer. General information on cancer staging and end-results reporting. In: Cancer Staging Handbook. Seventh edition, Heidelber: Springer; 2007, pp1-39.
16. F.A. Calvo, M. Gomez-Espí, and J.A. Diaz-González Pathologic downstaging of T3-4 Nx rectal cancer after chemoradiation-5- fluorouracil vs Tegafur Int J Radiat Oncol Biol Phys 51 2001 1264 1270
17. F.A. Calvo, F.J. Serrano, and J.A. Diaz-González Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction Oxaliplatin plus 5-fluorouracil and preoperative chemoradiation Ann Oncol 17 2006 1103 1110
18. C. Capirci, L. Rampin, and P. Erba Sequential FDG PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy Eur J Nucl Med 34 2007 1583 1593
19. R. Sauer, R. Fietkau, and C. Wittekind Adjuvant versus neo-adjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study Int J Radiat Oncol Biol Phys 57 2003 S124 S125
20. J.P. Gerard, O. Chapet, and C. Nemoz Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial J Clin Oncol 21 2003 1119 1124
21. M. Mohiuddin, W.F. Regine, J. Marks, and J.W. Marks High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum Int J Radiat Oncol Biol Phys 40 1998 569 574
22. M.H. Kam, D.C. Wong, and S. Sin Comparison of magnetic resonance imaging-fluorodeoxyglucose positron emission tomography fusion with pathological staging in rectal cancer Br J Surg 97 2010 266 268
23. T. Kav, and Y. Bayraktar How usefull is endosonography in the staging of rectal cancer World J Gastroenterol 6 2010 691 697
24. C. Rödel, R. Sauer, and R. Fietkau The role of magnetic resonance imaging to select patient for preoperative treatment in rectal cancer Strahlenther Onkol 185 2009 488 492
25. R.C. Dresen, G.L. Beets, and H.J. Rutten Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252 2009 71 80
26. P. Delrio, S. Lastoria, and A. Avallone Early evaluation using PET-FDG of the efficiency of neo-adjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum Tumori 89 2003 50 53
27. H. Young, R. Baum, and H. Cremerius Measurement of clinical and subclinical tumor response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1999 1773 1782
28. B.D. Chessin, T. Akhurst, and H. Yeung Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response: a prospective analysis J Clin Oncol 23 2005 3612
29. J.G. Guillem, T. Moore, and T. Akhurst Sequential FDG-PET imaging for detecting subclinical rectal cancer response to preoperative combined modality therapy J Am Coll Surg 199 2004 1 7
30. F.A. Calvo, M. Domper, and R. Matute 18F-FDG Positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation Int J Radiat Oncol Biol Phys 5882 2004 528 535
31. F.A. Calvo PET-CT scan in Oncology: an extraordinary health-care, teaching and investigator opportunity Rev Esp Med Nucl 26 2007 67 68
32. H. Amthauer, T. Deneke, and B. Rau Response prediction by FDG-PET after neo-adjuvant radiochemotherapy and combined hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology Eur J Nucl Med Mol Imaging 31 2004 811 819
33. T. Deneke, B. Rau, and K.T. Hoffmann Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15 2005 1658 1666
34. A.M. Scott, D.H. Gunawardana, and B. Kelley PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study J Nucl Med 49 2008 1451 1457